Lakefront Biotherapeutics NV LKFT
33.52 USD +0.07 (+0.21%)
At closeNov 9, 2026, 4:44 PM EST
33.52 0.00 0.00%
After hours · Nov 9, 4:44 PM ET
33.34 Day range 34.15
25.68 52-week range 36.24
- YTD
- +2.51%
- 1 year
- +6.31%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.11B | 275.65M | 239.72M | 241.25M | 234.38M | |
| 1.08B | 240.79M | 239.72M | 241.25M | 234.38M | |
| 295.04M | -188.34M | -88.26M | -131.06M | -171.57M | |
| 320.88M | 74.08M | 211.70M | -217.99M | -103.23M | |
| 4.87 | 1.12 | 3.21 | -3.32 | -1.58 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 87.87M | 64.24M | 166.80M | 508.12M | 2.23B | |
| 3.41B | 4.14B | 4.36B | 4.73B | 5.19B | |
| 170.65M | 1.24B | 1.56B | 2.21B | 2.55B | |
| 6.92M | 11.72M | 9.60M | 21.90M | 26.86M | |
| 3.24B | 2.90B | 2.80B | 2.53B | 2.64B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -307.90M | -417.26M | -463.90M | -488.49M | -493.52M | |
| 288.81M | 220.60M | 71.19M | -1.25B | 541.24M | |
| -3.27M | -4.92M | -5.00M | -1.49M | -3.88M | |
| -13.40M | -82.11M | -16.85M | -36.21M | -57.88M | |
| 28.09M | -104.35M | -339.79M | -1.75B | 33.53M |